Text-based Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program
NCT03119337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 780
Last updated 2020-03-18
Summary
Voluntary medical male circumcision (VMMC) in sub-Saharan Africa is safe: the average rate of moderate and severe adverse events (AEs) at the country level is 0.8%, corresponding to 99% of men healing without incident. To reach the global target of 20 million by 2018, VMMC productivity needs to double in countries already plagued by severe healthcare worker shortages like Zimbabwe. The ZAZIC consortium partners with the Zimbabwe Ministry of Health and Child Care (MoHCC) and performed over 120,000 VMMCs. Current VMMC care in Zimbabwe requires in-person, follow-up visits at post-operative days 2,7, and 42. Over 95% adhere to multiple follow-up visits within 14 days of VMMC. ZAZIC's program has an overall AE rate of 0.4%; therefore, overstretched clinic staff conducted more than 200,000 unnecessary reviews for VMMC clients without complications. High mobile phone ownership, severe healthcare worker shortages, and rapid VMMC scale up make ZAZIC's VMMC program an ideal setting to test a mobile health (mHealth) intervention to reduce provider workload while safeguarding patient safety. Through an un-blinded, prospective, randomized, control trial (RCT) in high-volume facilities providing VMMC, ZAZIC will implement an interactive, two-way texting (2wT) intervention to identify men healing without complication, allowing them to decline routine in-person follow up visits. 2wT will simultaneously identify men with any sign of an adverse event, encouraging rapid in-person follow-up when an AE is suspected on any day, reducing unnecessary visits while maintaining quality care. We aim to 1) determine if 2wT can safely reduce VMMC follow-up visits; 2) estimate the cost savings associated with 2wT over routine VMMC follow-up; and 3) assess the acceptability and feasibility of 2wT for further scale-up. It is expected that this intervention with be as safe as routine care while providing distinct advantages in terms of efficiency, costs, and reduced healthcare worker burden. This approach is innovative as it focuses on using a low-cost mHealth intervention to reduce provider workload without deterioration in quality care. The success of this intervention could lead to adoption of this intervention at the national level, increasing efficiency of VMMC scale up and reducing burdens on providers and patients
Conditions
- Voluntary Medical Male Circumcision
Interventions
- OTHER
-
Text-based follow-up
2wT clients will receive automated daily texts from days 1-14. If a 2wT VMMC client responds that he suspects an AE, a VMMC nurse will exchange modifiable, scripted texts with clients to determine symptoms, frequency, and severity. Then, if deemed necessary, the client will be asked to return to clinic the following day or earlier. If 2wT patients do not respond to texts on Day 2 or Day 7, the same MoHCC tracing process will be activated, after which they will be considered LTFU. All study participants will be asked to come to the clinic for study-specific, Day 14 follow-up to review healing and verify adverse event reporting. At Day 42, we will implement a brief text-based survey with 2wT clients to ascertain complete healing, providing stronger inferences at study completion.
Sponsors & Collaborators
-
Medic Mobile
collaborator INDUSTRY -
International Training and Education Center for Health
collaborator UNKNOWN -
ZICHIRe
collaborator UNKNOWN -
University of Zimbabwe
collaborator OTHER - lead OTHER
Principal Investigators
-
Caryl Feldacker, PhD, MPH · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-18
- Primary Completion
- 2019-02-28
- Completion
- 2019-08-30
Countries
- Zimbabwe
Study Locations
More Related Trials
-
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
NCT01019083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enhancing the A in SAFE for Trachoma
NCT05634759 ·Status: COMPLETED ·Phase: PHASE4
-
Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET"
NCT05276999 ·Status: COMPLETED ·Phase: NA
-
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
NCT01379326 ·Status: COMPLETED ·Phase: PHASE4
-
Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
NCT02899936 ·Status: COMPLETED ·Phase: NA
-
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
NCT05684887 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
NCT01385189 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women
NCT00148629 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of TT Cases by Community Treatment Assistants: An Assessment
NCT01783743 ·Status: COMPLETED ·Phase: NA
-
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
NCT00130910 ·Status: COMPLETED ·Phase: NA
-
Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage
NCT05684081 ·Status: UNKNOWN ·Phase: NA
-
Post Discharge Trial to Enhance Immunity in Severely Malnourished Children
NCT06530485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition
NCT01395381 ·Status: WITHDRAWN ·Phase: NA
-
Relative Efficacy of Two Regimens of Ante-helminthic Treatment
NCT00367627 ·Status: COMPLETED ·Phase: NA
-
Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
NCT03177993 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Multiple Behaviour Programme for Diarrhoea Management
NCT02081521 ·Status: COMPLETED ·Phase: NA
-
Impact of Home Zinc Treatment for Acute Diarrhea in Children
NCT00530829 ·Status: COMPLETED ·Phase: PHASE3
-
Mass Oral Cholera Vaccination in Zanzibar
NCT00709410 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts
NCT02864433 ·Status: COMPLETED
-
Improving Care Through Azithromycin Research for Infants in Africa
NCT04235816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Polio NID and Routine EPI Integration Trial Pakistan
NCT01697280 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi
NCT01213576 ·Status: TERMINATED ·Phase: NA
-
Impact of Training on Diarrhoea Management
NCT02143921 ·Status: COMPLETED ·Phase: NA
-
Single-dose Azithromycin for the Treatment of Yaws
NCT01382004 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Airtime Structure to Improve Interactive Voice Response Surveys in Bangladesh and Uganda
NCT03773146 ·Status: COMPLETED ·Phase: NA